Papers

BMJ

Volumn 318, Issue 7190, 1999, Pages 1035-1040

  Strachan, David P ^a   Carrington, David ^a   Mendall, Michael A ^a   Ballam, Lydia ^a   Morris, Julia ^a   Butland, Barbara K ^a   Sweetnam, Peter M ^b   Elwood, Peter C ^b   West, Robert r ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CARDIOVASCULAR RISK; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CLINICAL TRIAL; CORRELATION FUNCTION; DEATH CERTIFICATE; ELECTROCARDIOGRAM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MALE; MEDICAL RECORD; MORTALITY; NORMAL HUMAN; PLASMA VISCOSITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SEROPREVALENCE; STATISTICAL ANALYSIS; UNITED KINGDOM;

ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COHORT STUDIES; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PROSPECTIVE STUDIES; RISK FACTORS; WALES;

EID: 0033577551     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7190.1035     Document Type: Article

References (40)

1. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983–986.
2. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430–436.
3. Kuo CC, Shor A, Fukushi H, Patton DL, Campbell LA, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167: 841–847.
4. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996; 125: 979–982.
5. Jackson LA, Campbell LA, Schmidt RA, Kuo CC, Cappuccio AL, Lee MJ, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol 1997; 150: 1785–1790.
6. Saikku P. Chlamydia pneumoniae and atherosclerosis—an update. Scand J Infect Dis 1997; 104(suppl): 53–56.
7. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992; 116: 273–278.
8. Laurila A, Bloigu A, Näyhä S, Hassi J, Leinonen M, Saikku P. Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross-sectional study. BMJ 1997; 314: 1456–1457.
9. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711–714.
10. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein: determinants and relation to cardiovascular risk factors. BMJ 1996; 312: 1061–1065.
11. Miettinen H, Lehto S, Saikku P, Haffner SM, Rönnemaa T, Pyörälä K, et al. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 1996; 17: 682–688.
12. Ossewaarde JM, Feskens EJM, de Vries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998; 120: 93–99.
13. The Caerphilly and Speedwell Collaborative Group. The Caerphilly and Speedwell collaborative heart disease studies. J Epidemiol Community Health 1984; 38: 259–262.
14. Bainton D, Miller NC, Bolton CH, Yarnell JWG, Sweetnam PM, Baker IA, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. Br Heart J 1992; 68: 60–66.
15. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, et al. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836–844.
16. Office of Population Censuses and Surveys. Classification of occupations. London: HMSO, 1980.
17. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JG, Sweetnam PM, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischaemic heart disease in the Caerphilly prospective heart disease study. Circulation 1998; 98: 1286–1290.
18. Strachan DP, Carrington D, Mendall MA, Butland BK, Sweetnam PM, Elwood PC. Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study. Heart 1999; 81: 248–251.
19. Stata Corporation. STATA reference manual: release 3.1, 6th ed. College Station, TX: Stata, 1993.
20. Wagels G, Rasmussen S, Timms P. Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene. J Clin Microbiol 1994; 32: 2820–2823.
21. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levy J, et al. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect Dis 1995; 30: 121–128.
22. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998; 31: 827–832.
23. Davidson M, Kuo CC, Middaugh JP, Campbell LA, Wang SP, Newman III WP, et al. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 1998; 98: 628–633.
24. Morrison R, Belland R, Lyng K, Caldwell H. Chlamydial disease pathogenesis: the 57kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989; 170: 1271–1283.
25. Xu Q, Willeit J, Marosi M, Kleindienst R, Oberhollenzer F, Kiechi S, et al. Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Lancet 1993; 341: 255–259.
26. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary heart disease. JAMA 1992; 268: 68–72.
27. Hahn DL, Golubjatnikov R. Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. Arteriosclerosis Thrombosis 1992; 12: 945–947.
28. Karvonen M, Tuomilehto J, Pitkäniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 1994; 23: 1315–1321.
29. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997; 96: 404–407.
30. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350: 404–407.
31. Grayston JT, Kuo CC, Wang SI, Altman J. A new Chlamydia psittaci strain called TWAR from acute respiratory tract infections. N Engl J Med 1986; 315: 161–168.
32. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983–986.
33. Cook PJ, Honeybourne D, Lip CYH, Beevers DG, Wise R. Chlamydia pneumoniae and acute arterial thrombotic disease. Circulation 1995; 92: 3148–3149.
34. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997; 350: 430–436.
35. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992; 116: 273–278.
36. Miettinen H, Lehto S, Saikku P, Haffner SM, Rönnemaa T, Pyörälä K, et al. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 1996; 17: 682–688.
37. The Caerphilly and Speedwell Collaborative Group. The Caerphilly and Speedwell collaborative heart disease studies. J Epidemiol Community Health 1984; 38: 259–262.
38. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 1998; 98: 300–307.
39. Davies MJ. Acute coronary thrombosis: the role of plaque disruption and its initiation and prevention. Eur Heart J 1995; 16(suppl L): 3–7.
40. Gurfinkel E, Bozowich G, Daroca A, Beck E, Mautner B. Randomised trial of roxithromycin in non Q-wave coronary syndromes: ROXIS pilot study. Lancet 1997; 350: 404–407.